Heart disease, or coronary artery disease, is when the arteries supplying oxygen-rich blood to the heart muscle narrow or are blocked. This study will assess the effect of lowering low-density lipoprotein cholesterol (LDL-C) with the test drug on major cardiovascular events in adults without a prior myocardial infarction (MI) or stroke who are at high risk of a cardiovascular event.
Coronary artery disease clinical trials are underway in Little River, South Carolina, to help people with CHD manage and reduce the risks associated with the disease.
